Vanguard Group’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$133M Sell
1,959,463
-4,124
-0.2% -$258K ﹤0.01% 1737
2025
Q3
$112M Sell
1,963,587
-4,380
-0.2% -$260K ﹤0.01% 1810
2025
Q2
$109M Buy
1,967,967
+77,190
+4% +$3.62M ﹤0.01% 1795
2025
Q1
$82.7M Buy
1,890,777
+33,149
+2% +$1.44M ﹤0.01% 1877
2024
Q4
$80M Sell
1,857,628
-29,370
-2% -$1.32M ﹤0.01% 1957
2024
Q3
$84.3M Buy
1,886,998
+65,158
+4% +$2.69M ﹤0.01% 1949
2024
Q2
$70.1M Buy
1,821,840
+443,720
+32% +$16.9M ﹤0.01% 2010
2024
Q1
$47.5M Buy
1,378,120
+38,248
+3% +$1.23M ﹤0.01% 2193
2023
Q4
$38.8M Buy
+1,339,872
New +$30.5M ﹤0.01% 2291

Other funds holding DBD

Vanguard Group's DBD Position: Q4 2025 in Review

Vanguard Group reduced its Diebold Nixdorf (DBD) stake by 0.21% in Q4 2025, selling an estimated $258K and leaving 1,959,463 shares worth $133M. The position accounts for ﹤0.01% of the portfolio, ranked #1737.

Vanguard Group first reported a position in DBD in Q4 2023 and has held it in 9 quarters since. 173 funds tracked by Wall St. Rank hold DBD as of Q4 2025.

  • Vanguard Group held 1,959,463 shares of Diebold Nixdorf worth $133M as of Q4 2025.
  • Vanguard Group sold 4,124 Diebold Nixdorf shares in Q4 2025, an estimated $258K.
  • Diebold Nixdorf made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1737 holding.
  • Vanguard Group first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 9 quarters since.
  • 173 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.